|
G |
TNF |
tumor necrosis factor |
increases expression |
ISO |
platelet-activating factor increases expression of Tnf protein in portal stenosis rat plasma |
RGD |
PMID:10452877 |
RGD:38508900 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
PTGER4 |
prostaglandin E receptor 4 |
affects response to substance |
ISO |
PTGER4 protein affects the susceptibility to 8-isoprostaglandin E2 |
CTD |
PMID:22565502 |
|
NCBI chr 5:40,679,915...40,746,800
Ensembl chr 5:40,679,915...40,693,735
|
|
|
G |
APOE |
apolipoprotein E |
multiple interactions |
ISO |
[APOE gene mutant form affects the susceptibility to Folic Acid] which results in decreased abundance of 8-epi-prostaglandin F2alpha |
CTD |
PMID:17118406 |
|
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
|
|
G |
APP |
amyloid beta precursor protein |
multiple interactions increases abundance |
EXP |
[Lead co-treated with APP protein modified form] results in increased abundance of 8-epi-prostaglandin F2alpha APP protein modified form results in increased abundance of 8-epi-prostaglandin F2alpha |
CTD |
PMID:22610977 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions increases abundance increases chemical synthesis |
EXP ISO |
1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin F2alpha]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin F2alpha]; Ascorbic Acid inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin F2alpha]; Ascorbic Acid promotes the reaction [Aspirin inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin F2alpha]]; Aspirin inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin F2alpha]; Dehydroascorbic Acid inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin F2alpha]; Indomethacin inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin F2alpha]; Resveratrol inhibits the reaction [IL1B protein results in increased abundance of 8-epi-prostaglandin F2alpha] pyrrolidine dithiocarbamic acid inhibits the reaction [IL1B protein results in increased abundance of 8-epi-prostaglandin F2alpha]; Rotenone inhibits the reaction [IL1B protein results in increased abundance of 8-epi-prostaglandin F2alpha] |
CTD |
PMID:11530235 PMID:16529823 PMID:19751497 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
PAFAH2 |
platelet activating factor acetylhydrolase 2 |
affects metabolic processing multiple interactions |
ISO |
PAFAH2 protein affects the metabolism of 8-epi-prostaglandin F2alpha PAFAH2 protein affects the reaction [Carbon Tetrachloride results in increased abundance of 8-epi-prostaglandin F2alpha] |
CTD |
PMID:18024956 |
|
NCBI chr 1:25,959,767...25,998,063
Ensembl chr 1:25,959,767...25,998,117
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[L 745337 results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of 8-epi-prostaglandin F2alpha; [lipopolysaccharide, E. coli O26-B6 results in increased expression of PTGS2 protein] which results in increased chemical synthesis of 8-epi-prostaglandin F2alpha; [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of 8-epi-prostaglandin F2alpha |
CTD |
PMID:8621535 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
TBXA2R |
thromboxane A2 receptor |
multiple interactions affects response to substance |
EXP ISO |
8-epi-prostaglandin F2alpha binds to and results in increased activity of TBXA2R protein TBXA2R protein affects the susceptibility to 8-epi-prostaglandin F2alpha |
CTD |
PMID:18158556 PMID:22565502 |
|
NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
|
|
|
G |
ABCA8 |
ATP binding cassette subfamily A member 8 |
affects transport |
EXP |
ABCA8 protein affects the transport of Leukotriene C4 |
CTD |
PMID:12379217 |
|
NCBI chr17:68,867,289...68,955,392
Ensembl chr17:68,867,289...68,955,392
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
affects transport multiple interactions increases uptake decreases transport affects binding |
EXP |
ABCC1 protein affects the transport of Leukotriene C4 [Nimustine results in increased expression of ABCC1 protein] which results in increased transport of Leukotriene C4; Adenosine Triphosphate promotes the reaction [ABCC1 protein affects the transport of Leukotriene C4]; Apigenin inhibits the reaction [ABCC1 protein results in increased uptake of Leukotriene C4]; Bilirubin inhibits the reaction [ABCC1 protein affects the transport of Leukotriene C4]; estradiol-17 beta-glucuronide inhibits the reaction [ABCC1 protein affects the transport of Leukotriene C4]; Genistein affects the reaction [ABCC1 protein results in increased uptake of Leukotriene C4]; Glutathione Disulfide promotes the reaction [Leukotriene C4 analog binds to ABCC1 protein]; Glutathione promotes the reaction [Apigenin inhibits the reaction [ABCC1 protein results in increased uptake of Leukotriene C4]]; Glutathione promotes the reaction [Genistein affects the reaction [ABCC1 protein results in increased uptake of Leukotriene C4]]; Glutathione promotes the reaction [naringenin affects the reaction [ABCC1 protein results in increased uptake of Leukotriene C4]]; kaempferol inhibits the reaction [ABCC1 protein results in increased uptake of Leukotriene C4]; myricetin inhibits the reaction [ABCC1 protein results in increased uptake of Leukotriene C4]; naringenin affects the reaction [ABCC1 protein results in increased uptake of Leukotriene C4]; Quercetin inhibits the reaction [ABCC1 protein results in increased uptake of Leukotriene C4] ABCC1 protein mutant form results in decreased transport of Leukotriene C4 |
CTD |
PMID:9393752 PMID:11278867 PMID:11306701 PMID:15245331 PMID:15355964 PMID:15459206 PMID:15628876 PMID:18336795 More...
|
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
increases transport multiple interactions affects transport |
ISO EXP |
ABCC2 protein modified form results in increased transport of Leukotriene C4 verlukast inhibits the reaction [ABCC2 protein results in increased transport of Leukotriene C4] ABCC2 protein affects the transport of Leukotriene C4 |
CTD |
PMID:9430713 PMID:11500505 PMID:12388192 PMID:12395335 PMID:15507541 PMID:15904671 PMID:27676153 More...
|
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
multiple interactions |
EXP |
verlukast inhibits the reaction [ABCC3 protein results in increased transport of Leukotriene C4] |
CTD |
PMID:27676153 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
ABCC6 |
ATP binding cassette subfamily C member 6 |
affects transport |
EXP |
ABCC6 protein affects the transport of Leukotriene C4 |
CTD |
PMID:11880368 |
|
NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,522
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
multiple interactions |
EXP ISO |
[zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Leukotriene C4]; [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene C4 [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene C4 ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene C4]; zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene C4]] |
CTD |
PMID:9445378 PMID:9495842 PMID:10764316 PMID:12794006 |
|
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
ALOX5AP |
arachidonate 5-lipoxygenase activating protein |
multiple interactions |
EXP |
[2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid results in decreased activity of ALOX5AP protein] which results in decreased abundance of Leukotriene C4; [MK-886 results in decreased activity of ALOX5AP protein] which results in decreased abundance of Leukotriene C4 |
CTD |
PMID:9113110 |
|
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
|
|
G |
AMBP |
alpha-1-microglobulin/bikunin precursor |
decreases secretion |
ISO |
AMBP protein results in decreased secretion of Leukotriene C4 |
CTD |
PMID:9579392 |
|
NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328
|
|
G |
CCL13 |
C-C motif chemokine ligand 13 |
increases expression |
ISO |
Leukotriene C4 results in increased expression of CCL12 mRNA |
CTD |
PMID:12388339 |
|
NCBI chr17:34,356,480...34,358,610
Ensembl chr17:34,356,480...34,358,610
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
Leukotriene C4 results in increased expression of CCL2 mRNA |
CTD |
PMID:12388339 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CLEC7A |
C-type lectin domain containing 7A |
multiple interactions |
EXP |
CLEC7A protein promotes the reaction [Peptidoglycan results in increased metabolism of Leukotriene C4]; CLEC7A protein promotes the reaction [Zymosan results in increased metabolism of Leukotriene C4] |
CTD |
PMID:17030235 |
|
NCBI chr12:10,116,777...10,130,304
Ensembl chr12:10,116,777...10,130,258
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
Leukotriene C4 results in increased expression of CXCL1 mRNA |
CTD |
PMID:12388339 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CYSLTR1 |
cysteinyl leukotriene receptor 1 |
multiple interactions affects binding |
EXP ISO |
[Leukotriene C4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium; CGP 57698 inhibits the reaction [Leukotriene C4 binds to CYSLTR1 protein]; Leukotriene C4 binds to and results in increased activity of CYSLTR1 protein; MEN91507 inhibits the reaction [Leukotriene C4 binds to CYSLTR1 protein]; pobilukast inhibits the reaction [Leukotriene C4 binds to CYSLTR1 protein]; pranlukast inhibits the reaction [Leukotriene C4 binds to CYSLTR1 protein] CYSLTR1 protein binds to and affects the susceptibility to Leukotriene C4; Leukotriene C4 inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein] |
CTD |
PMID:8384568 PMID:10391245 PMID:10462554 PMID:10825389 PMID:11705452 PMID:11932261 PMID:11996896 PMID:12853847 More...
|
|
NCBI chr X:78,271,468...78,327,611
Ensembl chr X:78,271,468...78,327,691
|
|
G |
CYSLTR2 |
cysteinyl leukotriene receptor 2 |
multiple interactions increases activity |
EXP |
[Leukotriene C4 binds to and results in increased activity of CYSLTR2 protein] which results in increased abundance of Calcium; [Leukotriene C4 results in increased activity of CYSLTR2 protein] which results in increased abundance of Calcium; Leukotriene C4 binds to and results in increased activity of CYSLTR2 protein |
CTD |
PMID:10851239 PMID:11093801 |
|
NCBI chr13:48,653,929...48,711,226
Ensembl chr13:48,653,711...48,711,226
|
|
G |
EDN1 |
endothelin 1 |
increases expression multiple interactions |
EXP |
Leukotriene C4 results in increased expression of EDN1 mRNA; Leukotriene C4 results in increased expression of EDN1 protein zafirlukast inhibits the reaction [Leukotriene C4 results in increased expression of EDN1 mRNA]; zafirlukast inhibits the reaction [Leukotriene C4 results in increased expression of EDN1 protein] |
CTD |
PMID:11372388 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EGFR |
epidermal growth factor receptor |
increases expression |
ISO |
Leukotriene C4 results in increased expression of EGFR mRNA |
CTD |
PMID:12388339 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
GGT5 |
gamma-glutamyltransferase 5 |
multiple interactions |
EXP |
[Beclomethasone results in increased activity of GGT5 protein] which results in increased metabolism of Leukotriene C4; [Fluticasone results in increased activity of GGT5 protein] which results in increased metabolism of Leukotriene C4 |
CTD |
PMID:11447392 |
|
NCBI chr22:24,219,654...24,245,142
Ensembl chr22:24,219,654...24,245,108
|
|
G |
GPR17 |
G protein-coupled receptor 17 |
increases activity |
ISO |
Leukotriene C4 results in increased activity of GPR17 protein |
CTD |
PMID:18974869 |
|
NCBI chr 2:127,646,153...127,652,639
Ensembl chr 2:127,645,864...127,652,639
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
ISO |
Leukotriene C4 inhibits the reaction [Zymosan results in increased expression of HMOX1 protein] |
CTD |
PMID:11454666 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IL13 |
interleukin 13 |
increases expression multiple interactions increases abundance |
ISO |
Leukotriene C4 results in increased expression of IL13 mRNA [IL13 protein results in increased abundance of Leukotriene C4] which results in increased secretion of MUC5AC protein |
CTD |
PMID:12388339 PMID:12654629 |
|
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL5 |
interleukin 5 |
increases secretion |
EXP |
IL5 protein results in increased secretion of Leukotriene C4 |
CTD |
PMID:9378992 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
LTC4S |
leukotriene C4 synthase |
affects chemical synthesis |
EXP |
LTC4S protein affects the chemical synthesis of Leukotriene C4 |
CTD |
PMID:10666225 |
|
NCBI chr 5:179,793,986...179,796,647
Ensembl chr 5:179,793,980...179,796,647
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases phosphorylation |
ISO |
Leukotriene C4 results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:19837106 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases phosphorylation |
ISO |
Leukotriene C4 results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:19837106 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MGST1 |
microsomal glutathione S-transferase 1 |
multiple interactions |
ISO |
Leukotriene C4 binds to and results in decreased activity of MGST1 protein; Leukotriene C4 inhibits the reaction [Glutathione binds to and results in increased activity of MGST1 protein] |
CTD |
PMID:9890956 |
|
NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene C4 results in increased expression of MMP9 protein]; SB 203580 inhibits the reaction [Leukotriene C4 results in increased expression of MMP9 protein] |
CTD |
PMID:19837106 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
increases expression multiple interactions |
ISO |
Leukotriene C4 results in increased expression of MUC5AC mRNA; Leukotriene C4 results in increased expression of MUC5AC protein [IL13 protein results in increased abundance of Leukotriene C4] which results in increased secretion of MUC5AC protein |
CTD |
PMID:12654629 |
|
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Leukotriene C4 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] |
CTD |
PMID:11454666 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
PLA2G5 |
phospholipase A2 group V |
multiple interactions |
EXP ISO |
PLA2G5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Leukotriene C4] PLA2G5 protein promotes the reaction [Zymosan results in increased metabolism of Leukotriene C4] |
CTD |
PMID:9495842 PMID:14761945 |
|
NCBI chr 1:20,028,408...20,091,911
Ensembl chr 1:20,028,179...20,091,911
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
ISO |
PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased abundance of Leukotriene C4] |
CTD |
PMID:25432964 |
|
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
|
|
G |
RALBP1 |
ralA binding protein 1 |
multiple interactions affects transport |
EXP |
Adenosine Triphosphate promotes the reaction [RALBP1 protein affects the transport of Leukotriene C4]; Colchicine inhibits the reaction [RALBP1 protein affects the transport of Leukotriene C4] |
CTD |
PMID:15386349 |
|
NCBI chr18:9,475,009...9,538,114
Ensembl chr18:9,475,009...9,538,114
|
|
G |
SELP |
selectin P |
increases expression |
EXP |
Leukotriene C4 results in increased expression of SELP protein |
CTD |
PMID:9152370 |
|
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
|
|
G |
SYK |
spleen associated tyrosine kinase |
multiple interactions |
EXP |
SYK protein promotes the reaction [Peptidoglycan results in increased metabolism of Leukotriene C4]; SYK protein promotes the reaction [Zymosan results in increased metabolism of Leukotriene C4] |
CTD |
PMID:17030235 |
|
NCBI chr 9:90,801,600...90,898,549
Ensembl chr 9:90,801,787...90,898,549
|
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
increases abundance multiple interactions |
EXP ISO |
ALOX5 protein results in increased abundance of Leukotriene D4 ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene D4]; zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene D4]] [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene D4 |
CTD |
PMID:10764316 PMID:12629151 PMID:12794006 |
|
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
ARRB1 |
arrestin beta 1 |
multiple interactions |
EXP |
Leukotriene D4 promotes the reaction [CYSLTR2 protein binds to ARRB1 protein] |
CTD |
PMID:33288675 |
|
NCBI chr11:75,260,122...75,351,661
Ensembl chr11:75,260,122...75,351,705
|
|
G |
ARRB2 |
arrestin beta 2 |
multiple interactions |
EXP |
Leukotriene D4 promotes the reaction [CYSLTR2 protein binds to ARRB2 protein] |
CTD |
PMID:33288675 |
|
NCBI chr17:4,710,632...4,721,497
Ensembl chr17:4,710,596...4,721,499
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions |
EXP |
Leukotriene D4 promotes the reaction [CSF2 protein results in increased expression of TGFB1 protein] |
CTD |
PMID:15947480 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions |
EXP |
[Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein; zafirlukast inhibits the reaction [[Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein] |
CTD |
PMID:18704935 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYSLTR1 |
cysteinyl leukotriene receptor 1 |
multiple interactions affects binding increases activity increases response to substance |
EXP ISO |
[Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium; [Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium; [Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein; [Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of IL6 protein; [Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of TNF protein; alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol inhibits the reaction [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein]; BAY u9773 inhibits the reaction [[Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; BAY u9773 inhibits the reaction [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein]; BAY u9773 inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; CGP 57698 inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; CYSLTR1 protein promotes the reaction [Leukotriene D4 results in increased abundance of Calcium]; iralukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein; LY 171883 inhibits the reaction [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein]; MEN91507 inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; montelukast inhibits the reaction [[Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; montelukast inhibits the reaction [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein]; montelukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; pobilukast inhibits the reaction [[Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; pobilukast inhibits the reaction [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein]; pobilukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; pranlukast inhibits the reaction [[Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; pranlukast inhibits the reaction [CYSLTR1 protein results in increased susceptibility to Leukotriene D4]; pranlukast inhibits the reaction [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein]; pranlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; verlukast inhibits the reaction [[Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; verlukast inhibits the reaction [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein]; verlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; zafirlukast inhibits the reaction [[Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; zafirlukast inhibits the reaction [[Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein]; zafirlukast inhibits the reaction [[Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of IL6 protein]; zafirlukast inhibits the reaction [[Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of TNF protein]; zafirlukast inhibits the reaction [CYSLTR1 protein promotes the reaction [Leukotriene D4 results in increased abundance of Calcium]]; zafirlukast inhibits the reaction [CYSLTR1 protein results in increased susceptibility to Leukotriene D4]; zafirlukast inhibits the reaction [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein]; zafirlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein] [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium; CYSLTR1 protein binds to and affects the susceptibility to Leukotriene D4; Leukotriene C4 inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein; Leukotriene E4 inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; pranlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; verlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]; zafirlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein] |
CTD |
PMID:8014876 PMID:8384568 PMID:9620942 PMID:9647482 PMID:10391245 PMID:10462554 PMID:10825389 PMID:11093801 PMID:11705452 PMID:11932261 PMID:11996896 PMID:12853847 PMID:14718577 PMID:15792791 PMID:15990778 PMID:18651869 PMID:18704935 PMID:20083671 More...
|
|
NCBI chr X:78,271,468...78,327,611
Ensembl chr X:78,271,468...78,327,691
|
|
G |
CYSLTR2 |
cysteinyl leukotriene receptor 2 |
multiple interactions |
EXP |
[Leukotriene D4 binds to and results in increased activity of CYSLTR2 protein] which results in increased abundance of Calcium; [Leukotriene D4 binds to and results in increased activity of CYSLTR2 protein] which results in increased chemical synthesis of inositol 1-phosphate; [Leukotriene D4 results in increased activity of CYSLTR2 protein] which results in increased abundance of Calcium; BAY u9773 inhibits the reaction [[Leukotriene D4 binds to and results in increased activity of CYSLTR2 protein] which results in increased abundance of Calcium]; Leukotriene D4 binds to and results in increased activity of CYSLTR2 protein; Leukotriene D4 promotes the reaction [CYSLTR2 protein binds to ARRB1 protein]; Leukotriene D4 promotes the reaction [CYSLTR2 protein binds to ARRB2 protein]; montelukast inhibits the reaction [Leukotriene D4 binds to CYSLTR2 protein]; pranlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR2 protein]; verlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR2 protein]; zafirlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR2 protein] |
CTD |
PMID:10851239 PMID:11093801 PMID:33288675 |
|
NCBI chr13:48,653,929...48,711,226
Ensembl chr13:48,653,711...48,711,226
|
|
G |
FAS |
Fas cell surface death receptor |
decreases expression |
EXP |
Leukotriene D4 results in decreased expression of FAS protein |
CTD |
PMID:15990778 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
GPR17 |
G protein-coupled receptor 17 |
increases activity multiple interactions |
ISO |
Leukotriene D4 results in increased activity of GPR17 protein montelukast inhibits the reaction [Leukotriene D4 results in increased activity of GPR17 protein] |
CTD |
PMID:18974869 |
|
NCBI chr 2:127,646,153...127,652,639
Ensembl chr 2:127,645,864...127,652,639
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP |
Leukotriene D4 promotes the reaction [ICAM1 protein results in increased expression of TGFB1 protein] |
CTD |
PMID:15947480 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IL12A |
interleukin 12A |
multiple interactions |
EXP |
BAY u9773 inhibits the reaction [Leukotriene D4 results in increased secretion of [IL12A protein binds to IL12B protein]]; Leukotriene D4 results in increased secretion of [IL12A protein binds to IL12B protein]; montelukast inhibits the reaction [Leukotriene D4 results in increased secretion of [IL12A protein binds to IL12B protein]]; zileuton inhibits the reaction [Leukotriene D4 results in increased secretion of [IL12A protein binds to IL12B protein]] |
CTD |
PMID:19118273 |
|
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
|
|
G |
IL12B |
interleukin 12B |
multiple interactions |
EXP |
BAY u9773 inhibits the reaction [Leukotriene D4 results in increased secretion of [IL12A protein binds to IL12B protein]]; Leukotriene D4 results in increased secretion of [IL12A protein binds to IL12B protein]; montelukast inhibits the reaction [Leukotriene D4 results in increased secretion of [IL12A protein binds to IL12B protein]]; zileuton inhibits the reaction [Leukotriene D4 results in increased secretion of [IL12A protein binds to IL12B protein]] |
CTD |
PMID:19118273 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL13 |
interleukin 13 |
increases abundance multiple interactions |
ISO |
IL13 protein results in increased abundance of Leukotriene D4 [IL13 protein results in increased abundance of Leukotriene D4] which results in increased secretion of MUC5AC protein |
CTD |
PMID:12654629 |
|
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL5 |
interleukin 5 |
multiple interactions |
EXP |
Leukotriene D4 promotes the reaction [IL5 protein results in increased expression of TGFB1 protein] |
CTD |
PMID:15947480 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
IL6 |
interleukin 6 |
multiple interactions increases secretion |
EXP |
[Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of IL6 protein; BAY u9773 inhibits the reaction [Leukotriene D4 results in increased secretion of IL6 protein]; montelukast inhibits the reaction [Leukotriene D4 results in increased secretion of IL6 protein]; zafirlukast inhibits the reaction [[Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of IL6 protein]; zileuton inhibits the reaction [Leukotriene D4 results in increased secretion of IL6 protein] |
CTD |
PMID:18704935 PMID:19118273 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases phosphorylation |
ISO |
Leukotriene D4 results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:19837106 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases phosphorylation |
ISO |
Leukotriene D4 results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:19837106 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MGST1 |
microsomal glutathione S-transferase 1 |
decreases activity |
ISO |
Leukotriene D4 results in decreased activity of MGST1 protein |
CTD |
PMID:9890956 |
|
NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene D4 results in increased expression of MMP9 protein]; SB 203580 inhibits the reaction [Leukotriene D4 results in increased expression of MMP9 protein] |
CTD |
PMID:19837106 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions increases expression |
ISO |
[IL13 protein results in increased abundance of Leukotriene D4] which results in increased secretion of MUC5AC protein; verlukast inhibits the reaction [Leukotriene D4 results in increased expression of MUC5AC mRNA]; verlukast inhibits the reaction [Leukotriene D4 results in increased expression of MUC5AC protein] Leukotriene D4 results in increased expression of MUC5AC mRNA; Leukotriene D4 results in increased expression of MUC5AC protein |
CTD |
PMID:12654629 |
|
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
PDGFRB |
platelet derived growth factor receptor beta |
multiple interactions |
EXP |
6,7-dimethoxy-3-phenylquinoxaline inhibits the reaction [Leukotriene D4 results in increased phosphorylation of and results in increased activity of PDGFRB protein]; bisindolylmaleimide I inhibits the reaction [Leukotriene D4 results in increased phosphorylation of and results in increased activity of PDGFRB protein]; Leukotriene D4 promotes the reaction [SRC protein binds to PDGFRB protein]; Leukotriene D4 results in increased phosphorylation of and results in increased activity of PDGFRB protein; lipoxin A4 inhibits the reaction [Leukotriene D4 results in increased activity of PDGFRB protein]; pobilukast inhibits the reaction [Leukotriene D4 results in increased phosphorylation of and results in increased activity of PDGFRB protein] |
CTD |
PMID:12223454 |
|
NCBI chr 5:150,113,839...150,155,845
Ensembl chr 5:150,113,839...150,155,872
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
ISO |
PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased abundance of Leukotriene D4] |
CTD |
PMID:25432964 |
|
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
|
|
G |
SELP |
selectin P |
increases expression |
EXP |
Leukotriene D4 results in increased expression of SELP protein |
CTD |
PMID:9152370 |
|
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
|
|
G |
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions |
EXP |
Leukotriene D4 promotes the reaction [SRC protein binds to PDGFRB protein]; Leukotriene D4 results in increased phosphorylation of and results in increased activity of SRC protein; pobilukast inhibits the reaction [Leukotriene D4 results in increased activity of SRC protein] |
CTD |
PMID:12223454 |
|
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
EXP |
Leukotriene D4 promotes the reaction [CSF2 protein results in increased expression of TGFB1 protein]; Leukotriene D4 promotes the reaction [ICAM1 protein results in increased expression of TGFB1 protein]; Leukotriene D4 promotes the reaction [IL5 protein results in increased expression of TGFB1 protein] |
CTD |
PMID:15947480 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases secretion |
EXP |
[Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of TNF protein; BAY u9773 inhibits the reaction [Leukotriene D4 results in increased secretion of TNF protein]; montelukast inhibits the reaction [Leukotriene D4 results in increased secretion of TNF protein]; zafirlukast inhibits the reaction [[Leukotriene D4 results in increased activity of CYSLTR1 protein] which results in increased expression of TNF protein]; zileuton inhibits the reaction [Leukotriene D4 results in increased secretion of TNF protein] |
CTD |
PMID:18704935 PMID:19118273 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions increases response to substance |
ISO |
Cyclosporine inhibits the reaction [[AHR protein results in increased susceptibility to Antigens] which results in increased susceptibility to Methacholine Chloride] [AHR protein results in increased susceptibility to Antigens] which results in increased susceptibility to Methacholine Chloride; AHR protein results in increased susceptibility to Methacholine Chloride |
CTD |
PMID:27869817 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
BMPR2 |
bone morphogenetic protein receptor type 2 |
multiple interactions |
ISO |
BMPR2 protein affects the susceptibility to [Methacholine Chloride co-treated with Antigens, Dermatophagoides] |
CTD |
PMID:22427841 |
|
NCBI chr 2:202,376,327...202,567,749
Ensembl chr 2:202,376,327...202,567,751
|
|
G |
C3 |
complement C3 |
multiple interactions |
ISO |
C3 protein affects the susceptibility to [Ozone co-treated with Methacholine Chloride] |
CTD |
PMID:14701711 |
|
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
CACNA1E |
calcium voltage-gated channel subunit alpha1 E |
multiple interactions |
ISO |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid affects the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]]; Atropine inhibits the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]]; Calcium inhibits the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]]; Heparin affects the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]]; Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]; Ro 31-8425 inhibits the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]] |
CTD |
PMID:12663092 |
|
NCBI chr 1:181,317,699...181,808,084
Ensembl chr 1:181,317,690...181,813,262
|
|
G |
CFTR |
CF transmembrane conductance regulator |
multiple interactions |
EXP |
3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone inhibits the reaction [Methacholine Chloride promotes the reaction [CFTR protein results in increased export of Chlorides]]; Methacholine Chloride promotes the reaction [CFTR protein results in increased export of Chlorides] |
CTD |
PMID:20675434 |
|
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
|
|
G |
CPE |
carboxypeptidase E |
increases response to substance |
ISO |
CPE gene mutant form results in increased susceptibility to Methacholine Chloride |
CTD |
PMID:16002559 |
|
NCBI chr 4:165,379,008...165,498,547
Ensembl chr 4:165,361,194...165,498,547
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
multiple interactions |
ISO |
Ozone promotes the reaction [CXCR2 protein affects the susceptibility to Methacholine Chloride] |
CTD |
PMID:15361358 |
|
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
|
|
G |
FCER2 |
Fc epsilon receptor II |
increases expression |
EXP |
Methacholine Chloride results in increased expression of FCER2 protein |
CTD |
PMID:15801332 |
|
NCBI chr19:7,688,776...7,702,131
Ensembl chr19:7,688,758...7,702,146
|
|
G |
GRK3 |
G protein-coupled receptor kinase 3 |
affects response to substance |
ISO |
GRK3 mutant form affects the susceptibility to Methacholine Chloride |
CTD |
PMID:10198406 |
|
NCBI chr22:25,564,675...25,729,294
Ensembl chr22:25,564,675...25,729,294
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
multiple interactions increases expression |
ISO EXP |
IL1RN protein results in decreased susceptibility to [Ozone co-treated with Methacholine Chloride] Methacholine Chloride results in increased expression of IL1RN protein |
CTD |
PMID:14754758 PMID:15801332 |
|
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
LEP |
leptin |
increases response to substance |
ISO |
LEP gene mutant form results in increased susceptibility to Methacholine Chloride |
CTD |
PMID:12794034 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
NOS2 protein affects the reaction [2-chloroethyl ethyl sulfide affects the susceptibility to Methacholine Chloride] |
CTD |
PMID:22446026 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
decreases response to substance multiple interactions |
ISO |
NOS3 gene mutant form results in decreased susceptibility to Methacholine Chloride N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [NOS3 gene mutant form results in decreased susceptibility to Methacholine Chloride] |
CTD |
PMID:22421449 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
multiple interactions |
ISO |
NR1I2 protein affects the susceptibility to [5-alpha-Dihydroprogesterone co-treated with Methacholine Chloride] |
CTD |
PMID:17159084 |
|
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
[hydroquinone results in increased expression of TNF protein] which results in increased susceptibility to Methacholine Chloride; Chlorpromazine inhibits the reaction [[hydroquinone results in increased expression of TNF protein] which results in increased susceptibility to Methacholine Chloride]; Cromolyn Sodium inhibits the reaction [[hydroquinone results in increased expression of TNF protein] which results in increased susceptibility to Methacholine Chloride] |
CTD |
PMID:22414385 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
increases response to substance |
ISO |
TNFRSF1A protein results in increased susceptibility to Methacholine Chloride |
CTD |
PMID:21070800 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TRPC3 |
transient receptor potential cation channel subfamily C member 3 |
increases activity |
EXP |
Methacholine Chloride results in increased activity of TRPC3 protein |
CTD |
PMID:16522635 |
|
NCBI chr 4:121,874,481...121,952,060
Ensembl chr 4:121,874,481...121,952,060
|
|